9 stories
The intense demand for revolutionary weight loss drugs like Ozempic and Wegovy has inadvertently birthed a dangerous shadow industry. As legitimate supplies dwindle, desperate individuals are falling...
The rise of GLP-1 medications has sparked a worldwide frenzy, blurring the lines between medical necessity and cosmetic trends. We explore how the scramble for semaglutide is reshaping our approach to...
The fiercely competitive pharmaceutical world just got a lot more heated. The maker of blockbuster drug Ozempic has filed a lawsuit against a major competitor, alleging deceptive advertising practices...
Forget the old willpower debate. New weight-loss drugs like Wegovy and Mounjaro are targeting the brain’s hormonal signals to turn down the volume on hunger and reshape metabolic health.
As new weight-loss medications reshape national economies and personal lifestyles, we examine the deeper implications of a pharmaceutical revolution. This is more than a medical breakthrough; it is a...
England's Chief Medical Officer warns that while new weight-loss medications are powerful tools, relying on them to solve the obesity crisis ignores the root causes of a broken food environment.
A radical new pilot scheme is offering GP surgeries up to £3,000 to fast-track the rollout of weight-loss injections. As the NHS grapples with a burgeoning obesity crisis, the move marks a significant...
A generation of digital natives is facing an unexpected threat: a relentless stream of weight loss drug advertisements. The Children’s Commissioner is now calling for urgent action to fix the algorith...
The battle for supremacy in the booming weight-loss drug market has intensified, as Novo Nordisk, the maker of the blockbuster drug Wegovy, has launched a lawsuit against a rival. The pharmaceutical g...
